| Primary |
| Hypertension |
54.6% |
| Surgery |
4.0% |
| Essential Hypertension |
3.7% |
| Hypercholesterolaemia |
3.7% |
| Atrial Fibrillation |
3.3% |
| Depression |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Arterial Disorder |
2.9% |
| Hypothyroidism |
2.6% |
| Pain |
2.6% |
| Anxiety |
2.2% |
| Cardiac Disorder |
1.8% |
| Diabetes Mellitus |
1.8% |
| Dyslipidaemia |
1.8% |
| Prophylaxis |
1.8% |
| Angina Pectoris |
1.5% |
| Arteriosclerosis |
1.5% |
| Parkinsonism |
1.5% |
| Bronchitis |
1.1% |
| Cranial Nerve Disorder |
1.1% |
|
| Renal Failure Acute |
13.8% |
| Hyponatraemia |
11.3% |
| Vomiting |
7.5% |
| Malaise |
6.3% |
| Pruritus |
5.0% |
| Urticaria |
5.0% |
| Nausea |
3.8% |
| Rales |
3.8% |
| Rash Generalised |
3.8% |
| Renal Failure |
3.8% |
| Syncope |
3.8% |
| Thrombocytopenia |
3.8% |
| Tongue Dry |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Vasculitis |
3.8% |
| Weight Decreased |
3.8% |
| Weight Increased |
3.8% |
| Wheezing |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Ageusia |
2.5% |
|
| Secondary |
| Hypertension |
27.6% |
| Drug Use For Unknown Indication |
19.4% |
| Product Used For Unknown Indication |
16.7% |
| Prophylaxis |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Hypercholesterolaemia |
3.5% |
| Pain |
2.9% |
| Acute Coronary Syndrome |
2.3% |
| Gastroenteritis |
2.3% |
| Angina Pectoris |
2.1% |
| Epilepsy |
2.1% |
| Essential Hypertension |
2.1% |
| Arrhythmia |
1.8% |
| Diabetes Mellitus |
1.8% |
| Atrial Fibrillation |
1.2% |
| Cardiac Failure |
1.2% |
| Cardiovascular Disorder |
1.2% |
| Bronchitis |
0.9% |
| Cranial Nerve Disorder |
0.9% |
| Dyslipidaemia |
0.9% |
|
| Renal Failure Acute |
25.7% |
| Vomiting |
16.2% |
| Hyponatraemia |
8.1% |
| Hypotension |
4.1% |
| Renal Failure |
4.1% |
| Somnolence |
4.1% |
| Anaemia Haemolytic Autoimmune |
2.7% |
| Haematoma |
2.7% |
| Haemolytic Anaemia |
2.7% |
| Orthostatic Hypotension |
2.7% |
| Pancreatitis Acute |
2.7% |
| Pleural Effusion |
2.7% |
| Pregnancy |
2.7% |
| Pruritus |
2.7% |
| Pulmonary Fibrosis |
2.7% |
| Respiratory Failure |
2.7% |
| Syncope |
2.7% |
| Toxic Skin Eruption |
2.7% |
| Treatment Noncompliance |
2.7% |
| Tubulointerstitial Nephritis |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Hypertension |
18.8% |
| Drug Use For Unknown Indication |
18.5% |
| Type 2 Diabetes Mellitus |
6.0% |
| Diabetes Mellitus |
4.3% |
| Rheumatoid Arthritis |
3.8% |
| Hiv Infection |
2.8% |
| Hypercholesterolaemia |
2.6% |
| Multiple Myeloma |
2.5% |
| Prophylaxis |
2.5% |
| Cough |
2.3% |
| Breast Cancer |
2.2% |
| Bronchitis |
2.0% |
| Hepatitis C |
2.0% |
| Pain |
2.0% |
| Thrombosis Prophylaxis |
1.8% |
| Colorectal Cancer Metastatic |
1.4% |
| Premedication |
1.4% |
| Mantle Cell Lymphoma |
1.2% |
| Atrial Fibrillation |
1.1% |
|
| Vomiting |
17.1% |
| Renal Failure Acute |
10.8% |
| Renal Failure |
7.2% |
| Vertigo |
6.3% |
| Nasal Septum Disorder |
4.5% |
| Rash |
4.5% |
| Urinary Tract Infection |
4.5% |
| Urticaria |
4.5% |
| Weight Decreased |
4.5% |
| Injection Site Haematoma |
3.6% |
| Rhabdomyolysis |
3.6% |
| Staphylococcal Infection |
3.6% |
| Subileus |
3.6% |
| Swelling |
3.6% |
| Tachycardia |
3.6% |
| Tongue Oedema |
3.6% |
| Acute Myocardial Infarction |
2.7% |
| Atrial Fibrillation |
2.7% |
| Cardiac Failure |
2.7% |
| Hepatitis |
2.7% |
|
| Interacting |
| Hypertension |
31.3% |
| Drug Use For Unknown Indication |
12.5% |
| Prophylaxis |
12.5% |
| Essential Hypertension |
9.4% |
| Arrhythmia Supraventricular |
6.3% |
| Atrial Fibrillation |
6.3% |
| Osteoporosis |
6.3% |
| Angina Pectoris |
3.1% |
| Anxiety |
3.1% |
| Arrhythmia |
3.1% |
| Hypercholesterolaemia |
3.1% |
| Ventricular Arrhythmia |
3.1% |
|
| Orthostatic Hypotension |
23.1% |
| Renal Failure Acute |
15.4% |
| Urticaria |
15.4% |
| Vomiting |
15.4% |
| Malaise |
7.7% |
| Renal Failure |
7.7% |
| Syncope |
7.7% |
| Weight Decreased |
7.7% |
|
